Zevra Therapeutics Inc (ZVRA)

Nov 21, 2024

Zevra launches first FDA-approved NPC treatment - Investing.com India

Nov 21, 2024

Nov 21, 2024

Zevra Launches First FDA-Approved Treatment for Rare Niemann-Pick Disease | ZVRA Stock News - StockTitan

Nov 21, 2024

Nov 21, 2024

HC Wainwright Expects Lower Earnings for Zevra Therapeutics - MarketBeat

Nov 21, 2024

Nov 20, 2024

Zevra Therapeutics (NASDAQ:ZVRA) Earns "Buy" Rating from HC Wainwright - MarketBeat

Nov 20, 2024

Nov 20, 2024

Guggenheim Initiates Coverage of Zevra Therapeutics (ZVRA) with Buy Recommendation - MSN

Nov 20, 2024

Nov 20, 2024

Zevra Therapeutics (STU:1GDA) Enterprise Value : €424.12 Mil (As of Nov. 20, 2024) - GuruFocus.com

Nov 20, 2024

Nov 20, 2024

Zevra Therapeutics Q3 2024 Earnings Preview - MSN

Nov 20, 2024

Nov 20, 2024

Zevra Therapeutics (ZVRA) Reports Q3 Loss, Lags Revenue Estimates - MSN

Nov 20, 2024

Nov 18, 2024

(ZVRA) Technical Pivots with Risk Controls - Stock Traders Daily

Nov 18, 2024

Nov 18, 2024

ZVRA FY2024 EPS Forecast Decreased by Cantor Fitzgerald - MarketBeat

Nov 18, 2024

Nov 18, 2024

What is William Blair's Forecast for ZVRA FY2024 Earnings? - MarketBeat

Nov 18, 2024

Nov 16, 2024

Analysts Have Made A Financial Statement On Zevra Therapeutics, Inc.'s (NASDAQ:ZVRA) Third-Quarter Report - Yahoo Finance

Nov 16, 2024

Nov 15, 2024

Zevra testing beta blocker celiprolol for vEDS in Phase 3 US study - Ehlers-Danlos News

Nov 15, 2024

Nov 15, 2024

Simplify Asset Management Inc. Invests $833,000 in Zevra Therapeutics, Inc. (NASDAQ:ZVRA) - MarketBeat

Nov 15, 2024

Nov 15, 2024

What is William Blair's Estimate for ZVRA FY2026 Earnings? - MarketBeat

Nov 15, 2024

Nov 15, 2024

Here's What Analysts Are Forecasting For Zevra Therapeutics, Inc. (NASDAQ:ZVRA) After Its Third-Quarter Results - Simply Wall St

Nov 15, 2024

Nov 15, 2024

Roth Capital Forecasts Lower Earnings for Zevra Therapeutics - MarketBeat

Nov 15, 2024

Nov 15, 2024

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Sees Large Decline in Short Interest - MarketBeat

Nov 15, 2024

Nov 14, 2024

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 14, 2024

Nov 14, 2024

Earnings call: Zevra Therapeutics reports Q3 financial results - Investing.com

Nov 14, 2024

Nov 14, 2024

Canaccord Genuity Group Issues Pessimistic Forecast for Zevra Therapeutics (NASDAQ:ZVRA) Stock Price - MarketBeat

Nov 14, 2024

Nov 14, 2024

Q4 Earnings Forecast for ZVRA Issued By Roth Capital - MarketBeat

Nov 14, 2024

Nov 14, 2024

Zevra Therapeutics Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 14, 2024

Nov 13, 2024

Zevra Therapeutics' SWOT analysis: rare disease drug maker's stock poised for growth - Investing.com

Nov 13, 2024

Nov 13, 2024

Janney Montgomery Scott LLC Sells 127,755 Shares of Zevra Therapeutics, Inc. (NASDAQ:ZVRA) - MarketBeat

Nov 13, 2024

Nov 13, 2024

Zevra Therapeutics Inc (ZVRA) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Financial Challenges - GuruFocus.com

Nov 13, 2024

Nov 13, 2024

Zevra Therapeutics Inc (ZVRA) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst ... - Yahoo Finance

Nov 13, 2024

Nov 12, 2024

Zevra Therapeutics’ Transformative Third Quarter 2024 - TipRanks

Nov 12, 2024

Nov 12, 2024

Zevra Therapeutics: Q3 Earnings Snapshot - San Francisco Chronicle

Nov 12, 2024

Nov 12, 2024

Zevra Therapeutics earnings missed by $0.28, revenue fell short of estimates - Investing.com UK

Nov 12, 2024

Nov 12, 2024

Zevra Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Updates - The Manila Times

Nov 12, 2024

Nov 12, 2024

Zevra Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024

Nov 12, 2024

Zevra Therapeutics Inc (ZVRA) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst ... By GuruFocus - Investing.com Canada

Nov 12, 2024

Nov 11, 2024

Zevra Therapeutics to Present Data Demonstrating Relevance of Swallow Domain in Niemann-Pick Disease Type C Clinical Severity Scale at 53rd Child Neurology Society Annual Meeting - The Manila Times

Nov 11, 2024

Nov 11, 2024

Zevra Therapeutics Inc (ZVRA) Q3 2024: Everything You Need To Kn - GuruFocus.com

Nov 11, 2024

Nov 11, 2024

Zevra Therapeutics Validates Key Clinical Scale for Niemann-Pick Disease Treatment Study | ZVRA Stock News - StockTitan

Nov 11, 2024

Nov 08, 2024

International Assets Investment Management LLC Raises Position in Zevra Therapeutics, Inc. (NASDAQ:ZVRA) - Defense World

Nov 08, 2024

Nov 07, 2024

(ZVRA) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Nov 07, 2024

Nov 07, 2024

ZVRA stock touches 52-week high at $8.96 amid market rally - Investing.com India

Nov 07, 2024

Nov 07, 2024

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Receives $20.83 Average PT from Analysts - MarketBeat

Nov 07, 2024

Nov 06, 2024

Zevra Therapeutics to Participate at the Guggenheim Securities Healthcare Innovation Conference on Wed, Nov. 13 - The Manila Times

Nov 06, 2024

Nov 06, 2024

Zevra Therapeutics CEO to Present at Guggenheim Healthcare Conference | ZVRA Stock News - StockTitan

Nov 06, 2024

Nov 05, 2024

Zevra Therapeutics (ZVRA) to Release Quarterly Earnings on Tuesday - MarketBeat

Nov 05, 2024

Nov 05, 2024

Vanguard Group Inc's Strategic Acquisition in Zevra Therapeutics Inc - GuruFocus.com

Nov 05, 2024

Oct 31, 2024

Zevra Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Nov. 12, 2024 - The Manila Times

Oct 31, 2024

Oct 29, 2024

Earnings Preview: Zevra Therapeutics (ZVRA) Q3 Earnings Expected to Decline - Yahoo Finance

Oct 29, 2024

Oct 28, 2024

How To Trade (ZVRA) - Stock Traders Daily

Oct 28, 2024

Oct 24, 2024

Rare Disease Spotlight: Niemann-Pick pipeline behind two approvals - BioCentury

Oct 24, 2024

Oct 22, 2024

Will Zevra Gallop Or Saunter In Q3? - RTTNews

Oct 22, 2024

Oct 17, 2024

Objective long/short (ZVRA) Report - Stock Traders Daily

Oct 17, 2024

Oct 17, 2024

Sanctuary Advisors LLC Makes New $474,000 Investment in Zevra Therapeutics, Inc. (NASDAQ:ZVRA) - MarketBeat

Oct 17, 2024

Oct 17, 2024

Zevra therapeutics director Corey Watton buys $3,957 in stock - Investing.com India

Oct 17, 2024

Oct 16, 2024

Zevra therapeutics director Corey Watton buys $3,957 in stock By Investing.com - Investing.com Australia

Oct 16, 2024

Oct 14, 2024

Zevra Stock Surges Close to 70% in 3 Months: Here's Why - MSN

Oct 14, 2024

Oct 13, 2024

Brokerages Set Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Price Target at $20.83 - MarketBeat

Oct 13, 2024

Oct 13, 2024

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Short Interest Up 25.7% in September - MarketBeat

Oct 13, 2024